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Neural crest-derived pigment cell development has been used extensively to study cell fate specification, migration, proliferation, survival and
differentiation. Many of the genes and regulatory mechanisms required for pigment cell development are conserved across vertebrates. The
zebrafish mutant colgate (col)/histone deacetylase1 (hdac1) has reduced numbers, delayed differentiation and decreased migration of neural crest-
derived melanophores and their precursors. In hdac1col mutants normal numbers of premigratory neural crest cells are induced. Later, while there
is only a slight reduction in the number of neural crest cells in hdac1col mutants, there is a severe reduction in the number of mitfa-positive
melanoblasts suggesting that hdac1 is required for melanoblast specification. Concomitantly, there is a significant increase in and prolonged
expression of foxd3 in neural crest cells in hdac1col mutants. We found that partially reducing Foxd3 expression in hdac1col mutants rescues mitfa
expression and the melanophore defects in hdac1col mutants. Furthermore, we demonstrate the ability of Foxd3 to physically interact at the mitfa
promoter. Because mitfa is required for melanoblast specification and development, our results suggest that hdac1 is normally required to
suppress neural crest foxd3 expression thus de-repressing mitfa resulting in melanogenesis by a subset of neural crest-derived cells.
© 2007 Elsevier Inc. All rights reserved.Keywords: Neural crest; Melanophore; Histone deacetylase1; foxd3; mitfa; c-kit; ZebrafishIntroduction
The neural crest is an embryonic cell population that gives
rise to pigment cells, craniofacial cartilage and neurons and glia
of the peripheral nervous system among other cell types
(LeDouarin and Kalcheim, 1999). Neural crest cell-derived
pigment cell development has been studied extensively, aided by
a large number of pigment mutant loci in mice as well as
zebrafish. There are more than 800 coat color alleles identified in
mice, corresponding to 127 genetic loci (Bennett and Lamoreux,
2003). Similarly, almost 100 pigmentation mutants have been
identified in multiple genetic screens in zebrafish (Henion et al.,
1996; Kelsh et al., 1996; Odenthal et al., 1996). In birds and
mammals, melanocytes are the only neural crest-derived pigment
cells present. In contrast, there are three types of pigment cells or
chromatophores present in zebrafish. They are the black,⁎ Corresponding author. Fax: +1 614 292 5379.
E-mail address: henion.1@osu.edu (P.D. Henion).
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doi:10.1016/j.ydbio.2007.10.045melanin-containing melanophores, the yellow, pteridine-con-
taining xanthophores and the iridescent, purine-containing
iridiphores. Henceforth, we will use the term melanophore to
describe zebrafish, avian and mammalian melanocytes.
Identification of many of the genes involved in pigment cell
development has revealed that, by and large, regulation of
melanophore development is conserved among vertebrates. One
such conserved gene is microphthalmia-associated transcrip-
tion factor (mitf) which is a critical regulator of melanophore
development. In humans, defects in MITF are associated with
type 2a Waardenberg syndrome, which is characterized by
hypopigmentation and deafness (Steingrimsson et al., 2004;
Widlund and Fisher, 2003). Additionally, in humans, MITF is
also found to be amplified in a fraction of malignant melanomas
and can function as an oncogene (Garraway et al., 2005;
Widlund and Fisher, 2003). Similar to defects in humans, the
zebrafish mitfa mutant, nacre, completely lacks melanophores
(Lister et al., 1999). The requirement for mitf in melanophore
development is further underscored by experiments in which
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ted cells and misexpression of Mitf in NIH/3T3 fibroblasts
resulted in their conversion into a melanophore-like cell fate
(Lister et al., 1999; Tachibana et al., 1996). In mice, mutations
in Mitf reveal that in addition to a loss of melanophores, there
are also variable defects in the eyes, osteoblasts and mast cell
development depending on the severity of the mutations
(reviewed by Steingrimsson et al., 2004; Widlund and Fisher,
2003). In zebrafish, there are two mitf co-orthologues, mitfa and
mitfb, with mitfa being required for melanophore development
(Lister et al., 1999; Lister et al., 2001). mitf regulates the
expression of multiple genes within the melanophore lineage
including tyrosinase, tryp1, dct, c-kit and bcl2 (reviewed in
Steingrimsson et al., 2004).
Given the central function of mitf in melanophore
development, several genes and gene pathways have been
shown to affect melanophore development via mitf at the
transcriptional and post transcriptional level. Transcription
factors and pathways that positively regulate mitf at the
promoter level include CREB, sox10, pax3 and lef1/wnt/β-
catenin signaling (Bertolotto et al., 1998; Bondurand et al.,
2000; Dorsky et al., 2000; Elworthy et al., 2003; Lee et al.,
2000; Potterf et al., 2000; Price et al., 1998b; Saito et al., 2002;
Takeda et al., 2000; Verastegui et al., 2000). Consistent with
requirements of pax3 and sox10 for mitf expression, human
mutations in PAX3 and SOX10 cause subtypes of Waardenburg
syndromes, which overlap with hypopigmentation associated
with type 2a Waardenburg syndrome caused by defects inMITF
(Pingault et al., 1998; Read and Newton, 1997; Steingrimsson et
al., 2004). At the post translation level, the protoonco-receptor
tyrosine kinase c-kit, via phosphorylation, affects Mitf protein
activity and stability (Price et al., 1998a; Wu et al., 2000; Xu
et al., 2000).
The transcription factors sox10, pax3 and lef1 positively
regulate mitfa transcription yet are also expressed and required
by the precursors of other neural crest derivatives. Thus, it is not
presently known how sox10, pax3 and lef1 specify melano-
phores within the neural crest cell population. It is likely that
there are additional levels of regulation of mitfa and/or other
transcription factors in specifying melanogenic cell fate. A
potential candidate for the regulation of melanophore specifica-
tion is the Winged-Helix transcription factor foxd3. foxd3
expression is induced in cells at the neural plate border and is
extinguished prior to the initial expression of melanogenic
sublineage-specific genes such as mitf (Kos et al., 2001;
Odenthal and Nusslein-Volhard, 1998). Overexpression of
foxd3 in avian embryos represses melanogenesis whereas
morpholino-mediated knockdown in avian neural crest cultures
promotes melanogenesis (Kos et al., 2001). However, the
mechanism by which foxd3 functions in melanophore develop-
ment has not yet been established. Seemingly contrary to
predictions from avians, in zebrafish foxd3 mutants and
morphants, melanophore development is largely normal (Lister
et al., 2006; Montero-Balaguer et al., 2006; Stewart et al.,
2006). This apparent inconsistency is not presently understood.
In our study, we take advantage of the co1b382 mutation,
which we have shown encodes histone deacetylase 1 (hdac1;Nambiar et al., 2007), in which there is a severe disruption of
the specification, migration and differentiation of melano-
phores. We show that in hdac1col mutants there is a
misregulation of foxd3 expression such that foxd3 expression
is extended for a prolonged period of time in neural crest cells
compared to wild-type embryos. The melanophore phenotype
in hdac1col mutants, including mitfa expression, migration and
overt differentiation, can be selectively rescued by a partial
repression of foxd3 expression. Furthermore, we demonstrate
by EMSA binding of in vitro translated Foxd3 protein to two
putative Foxd3 binding sites of the mitfa promoter within a
region capable of driving melanophore-specific expression
(Dorsky et al., 2000), suggesting the possibility that foxd3 can
repress melanophore specification and melanogenesis by
directly inhibiting mitfa expression. Our results indicate that
hdac1 is normally required, directly or indirectly, to repress
foxd3 expression, and foxd3 repression is required to permit




Adult zebrafish and embryos were raised and maintained at 28.5 °C in the
Ohio State University zebrafish facility. hdac1col−/− mutant embryos were
obtained by pair wise matings of heterozygous adult zebrafish that were
maintained in AB and WIK backgrounds. Embryos were staged according to
Kimmel et al. (1995). In order to determine the genotype of embryos before a
visible phenotype was clearly apparent, genomic DNA from individual embryos
was obtained and PCR was performed using chromosome 19-linked
polymorphic SSLP markers that have been shown to be closely linked to the
hdac1col locus (Knapik et al., 1996; Nambiar and Henion, 2004; Nambiar et al.,
2007). The hdac1col+/−; foxd3zdf10+/− double mutant line was created by crossing
foxd3zdf10+/− (Stewart et al., 2006) heterozygous carriers, formerly known
as foxd3sym1, to hdac1col+/− (b382) heterozygous carriers and double mu-
tant embryos genotyped using the markers above and SSLP markers for the
foxd3zdf10 locus (Stewart et al., 2006).
In situ hybridization
In situ hybridization was carried out on staged embryos as described
previously (Thisse et al., 1993) with minor modifications. Embryos over 24 hpf
were raised in 0.03 g/l 1-phenyl-2-thiourea (PTU) to prevent melanin synthesis.
Probes used were tfap2a (Knight et al., 2003), c-kit (Parichy et al., 1999),
crestin (Luo et al., 2001; Rubinstein et al., 2000), dct (Kelsh et al., 2000a),
fms and xdh (Parichy et al., 2000a,b), foxd3 (Kelsh et al., 2000b; Odenthal
and Nusslein-Volhard, 1998), snai1b (Thisse et al., 1995), sox9b (Li et al.,
2002), sox10 (Dutton et al., 2001) and th (An et al., 2002).
Melanophore cell counts, statistical and image analysis
Melanophore cell counts were performed between somites 5 and 15 in the
dorsal, ventral and lateral stripes under a dissecting microscope. In order to
facilitate counts, embryos were first treated with epinephrine for 5 min to
contract the melanosomes (Johnson et al., 1995; Parichy et al., 1999; Rawls and
Johnson, 2000). Melanosome contraction in hdac1col mutants took between 15
and 20 min. Embryos were then fixed in 4% paraformaldehyde in PBS. Cell
counts were carried out at 60 hours post fertilization (hpf), 5 days post
fertilization (dpf), and 8 dpf in wild-type and mutant embryos. For each time
point, between 7 and 11 embryos were counted and data analyzed using 2-way
ANOVA and Bonferroni post hoc tests. Graph prism pad version 4.0 software
was used to conduct statistical analysis and graph data. Embryos were examined
Fig. 1. Melanophore development is defective in hdac1col mutants. Lateral
views of live embryos at 27 hpf (A, B) and 3 dpf (C, D). (A, B) At 27 hpf in
wild-type embryos melanophores are present posterior to the eye and otic vesicle
and are migrating over the flank of the embryo. In hdac1col mutants, there are
fewer melanophores and most of the melanophores are located posterior to the
otic vesicle (arrowhead). There are no migrating melanophores in hdac1col
mutants. (C, D) By 3 dpf, melanophores are present in four stripes in wild-type:
dorsal (d), lateral (l), ventral (v) and yolk (y). In hdac1col mutants melanophore
numbers do not recover. Melanophores present in hdac1col fail to migrate and
are mainly localized to the dorsal stripe and a patch of melanophores posterior to
the otic vesicle (arrows, arrowhead). Melanophores that do migrate ventrally in
hdac1col mutants are present in the anterior ventral stripe over the yolk
extension. Xanthophores, which give a yellowish hue to embryos, are present in
the head and over the flank of wild-type embryos and hdac1col mutants.
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digital camera and SPOT v4.0-software, and figures were assembled using
Photoshop CS2. In some figure panels, to analyze complete embryos, images of
embryos that were captured in the same positions but at slightly different focal
planes were fused together using Photoshop CS2.
Morpholino injections
The foxd3 morpholino is a translation blocking morpholino (Stewart et al.,
2006). The sequence of the morpholino is as follows: 5′ CAC CGC GCA CTT
TGC TGC TGG AGC A 3′ (Gene tools Inc.). The concentration of morpholino
used in experiments was 0.25 mM. Complete phenocopy of foxd3zdf10 was
achieved by injecting 20 ng of morpholino per embryo (Stewart et al., 2006). In
our experiments 0.477–1.1 ng of morpholino was injected per embryo which
partially knocks down Foxd3 (Supplementary Fig. 1). Uninjected embryos from
heterozygous carrier crosses were used as controls.
EMSAs
Electrophoretic mobility shift assays (EMSAs) were performed using in
vitro translated proteins as described previously (Voronina et al., 2004). Foxd3
protein was synthesized from pCS2/Foxd3 in vitro (Lister et al., 2006) (Quick
TNT Linked In Vitro Transcription/Translation Kit; Promega) with the addition
of [35S]-methionine (Amersham). Proper translation was verified by SDS–
PAGE and autoradiography. EMSAs were performed using annealed double-
stranded oligonucleotide probes representing the predicted forkhead binding
sites from the mitfa promoter (GenBank accession # AF211890), Site 1
(nucleotides 579–595; Site 1 wt F: 5′-ATG CTG AGA ACA AAC AAT GTT
TTATGC AG) and Site 2 (nucleotides 750–766; Site 2 wt F: 5′-CGT TTG GGT
AAA AAA AAC AAT ATG AGA AGA). For competitions, a 100-fold molar
excess of unlabeled double-stranded oligonucleotide was included. Competitors
used represented the wild-type or mutated Site 1 or Site 2 or the unrelated oct1
binding site, OCTA (Hinkley and Perry, 1991), Site 1 mut F: 5′-ATG CTG ATg
gCA ggg gAT GTT TTATGC AG Site 2 mut F: 5′-CGT TTG GGT Agg gAA
gga gAT ATG AGA AGA (changed bases are in lower case).
Results
The zebrafish mutant colgate (co1b382) is an ENU-induced,
recessive larval lethal mutation (Henion et al., 1996; Nambiar
and Henion, 2004). Mutants die between 7 and 9 dpf. The
co1b382 mutant was originally isolated in a screen for mutants
with defects in neural crest development and was identified
based on an abnormal melanophore pigment pattern (Henion
et al., 1996). The co1b382 locus was recently identified as his-
tone deacetylase1 (hdac1; Nambiar et al., 2007).
Melanophore development is abnormal in hdac1col mutants
In wild-type embryos at 27 hpf, differentiated (melanin
granule-containing) melanophores are found just posterior to
the eye and posterior to the otic vesicle (Fig. 1A). By 2 dpf,
these melanophores have migrated dorsally and anteriorly over
the head away from their site of origin (Knight et al., 2003;
Schilling and Kimmel, 1994). In the trunk of wild-type embryos
at 3 dpf (Fig. 1C), melanophores are organized into distinct
dorsal, lateral, ventral and yolk stripes (Kelsh et al., 1996;
Schilling and Kimmel, 1994). In hdac1col mutants at 27 hpf, the
total number of melanophores is reduced (Fig. 1B) and those
present are located just posterior to the otic vesicle. Addition-
ally, the hdac1col mutant melanophores are hypopigmented
compared to wild type. Later in hdac1col mutants, at 2 dpf and3 dpf, the melanophores that arise in the post otic region fail to
migrate and instead form a distinctive patch of cells (data not
shown, see Fig. 1D). At 3 dpf, most of the melanophores in the
trunk fail to migrate and instead are located in the dorsal stripe.
hdac1colmutants, compared to wild-type embryos, have fewer
melanophores in the ventral stripe and only occasional
melanophores are present in the lateral stripe. Additionally,
only 0–6 melanophores migrate into the ventral stripe in the tail
region in hdac1col mutants as compared to wild-type embryos,
where there are numerous melanophores present. The yolk sac
stripe is absent in hdac1col mutants and any individual
melanophores present on the yolk are located anteriorly, close
to the heart and near the post otic patch of melanophores. To
quantify the melanophore phenotype, melanophore cell counts
were performed in wild-type and hdac1col mutant embryos
between somites 5 and 15 at 60 hpf, 5 dpf and 8 dpf (Table 1,
A). Cell counts are a sum of the dorsal, lateral and ventral stripe
melanophores. At 60 hpf, hdac1col embryos have only 59% of
the number of melanophores present in wild-type embryos. The
deficit in melanophore number in hdac1col mutants recovers
slightly to 63% of wild-type melanophores by 5 dpf. At 8 dpf,
while wild-type melanophore numbers are the same as at 5 dpf,
there is a decrease in melanophore numbers to 53% of wild-type
in hdac1col mutants. This indicates that between 5 and 8 dpf,
some existing melanophores in hdac1col mutants die or are
demelanized.
The migration of melanophores was calculated as a per-
centage of melanophores present in the ventral stripe to the total
number of melanophores present in the dorsal, lateral and ventral
Table 1
Reduced melanophore number and migration in hdac1col mutants compared to wild-type
Hours/days
post fertilization
Trunk melanophores (±1 SD) Percentage of
wt melanophores
in hdac1col (%)
Melanophore # Melanophore migration {Ventral (%)a}
wt hdac1col wt hdac1col
60 hpf 110±6.98 65.13±8.44*** 41.24±2.99 22.27±9.64*** 59.13
5 dpf 143±6.5 90.64±11.26*** 43.13±2.66 19.18±6.5*** 63.38
8 dpf 135.63±7.67 72.36±12.3*** 45.69±2.44 23.16±6.96*** 53.35
Significantly lower melanophore numbers were present at all times post fertilization (***, Pb0.001) in hdac1col mutants compared to wild-type. In addition to lower
melanophore numbers significant impairment of melanophore migration was also noticed in hdac1col mutants when compared to wild-type controls at 2.5, 5 and 8 dpf
(***, Pb0.001). Melanophore counts were performed in somite 5 through 15 in the dorsal, lateral and ventral stripe. n=8–11/group were counted at 60 hpf (2.5 dpf),
5 dpf and 8 dpf. Melanophore migration {Ventral (%)a}; migration is calculated as a percentage of melanophores in the ventral stripe to the total number of
melanophores in the dorsal, ventral and lateral stripes. Two-way ANOVAwith Bonferroni post hoc test was used to analyze data.
571M.S. Ignatius et al. / Developmental Biology 313 (2008) 568–583stripes. In wild-type embryos at 60 hpf to 8 dpf between 41 and
46% of the total melanophores are present in the ventral stripe. In
contrast, in hdac1col mutants, only 19–23% (Table 1, B) of the
total melanophores are present in the ventral stripe. The mela-
nophore defects do not recover in hdac1col mutants. In contrast
to melanophore development, xanthophore numbers and migra-
tion patterns, although initially delayed, are equivalent to
wild-type embryos by 3 dpf in hdac1col mutants (Figs. 1C, D).
hdac1col is required for melanophore specification, migration
and differentiation
The reduced number of melanophores and their abnormal
migration in hdac1col mutant embryos led us to examine
whether there are differences in the expression of genes required
for melanoblast specification, differentiation, migration and
survival between wild-type and hdac1col mutants. mitfa is a
critical regulator of melanophore development that is required
to specify melanoblasts beginning at the 17–18 somite stage
(Lister et al., 1999). In hdac1col mutants, mitfa expression is
delayed by approximately 1 h (data not shown). Later quali-
tatively, at 20 somites (data not shown) and at 25 hpf (Figs. 2A,
B, G, H), there are fewer mitfa-positive melanoblasts specified
compared to wild-type embryos. Furthermore, in hdac1col
mutants, the expression of mitfa in the trunk does not extend as
far caudal as in wild-type embryos and there are fewer
melanoblasts migrating ventrally as compared to wild-type
embryos. At 30 hpf (Supplementary Figs. 2A, B), there are still
fewer mitfa-positive melanoblasts in hdac1col mutants com-
pared to wild-type and most of these cells are located in the
dorsal stripe and in the post otic region, suggesting a general
disruption of melanoblast migration. At 48 hpf (Figs. 3A, B),
mitfa is downregulated in most differentiating melanoblasts inwild-type embryos. In contrast, mitfa continues to be expressed
in the reduced number of melanoblasts present in hdac1col
mutants, suggesting a failure in the downregulation of mitfa.
Additionally, mitfa-positive melanoblasts in hdac1col mutants
have still not migrated at this stage and are predominantly
located in the post otic region and the dorsal stripe.
We also examined the expression of c-kit, a receptor tyrosine
kinase required for migration and survival of melanoblasts
(Parichy et al., 1999) in wild-type and hdac1col mutants. By
25 hpf, the majority of the mitfa-positive melanoblasts also
express c-kit. c-kit is expressed in migrating melanoblasts in the
head and trunk regions. In addition to melanoblasts, c-kit is also
expressed in the posterior notochord, near the anus, in the retina
and in the branchial arches in wild-type embryos (Parichy et al.,
1999). In hdac1col mutants, very few c-kit-expressing melano-
blasts are present at 25 hpf (Figs. 2C, D, I, J), 30 hpf
(Supplementary Figs. 2C, D) and 36 hpf (data not shown). In
addition, c-kit expression in the few c-kit-positive melanoblasts
in hdac1col is also reduced when compared to the robust
expression in wild-type melanoblasts. Later, by 48 hpf, the
numbers of c-kit-positive melanoblasts and expression within
melanoblasts do not recover to wild-type levels in hdac1col
mutants (Figs. 3C, D). In contrast to expression in melano-
blasts in hdac1col mutants, c-kit expression in the branchial
arches and near the anus is normal and equivalent to wild-type
embryos at equivalent stages. This suggests that the reduction/
absence of c-kit expression in hdac1col mutants is specific to
melanoblasts.
Dopachrome tautamerase (dct) is an enzyme required for
melanin synthesis and hence an indicator of melanoblast
differentiation (Kelsh et al., 2000a). In wild-type embryos dct
is robustly expressed in differentiating melanoblasts in the head
and in the trunk including migrating melanoblasts beginning at
Fig. 2. Fewer melanoblasts are specified in hdac1col embryos. Lateral and dorsal (cranial region) views of 25 hpf embryos that are stained by in situ hybridization to
reveal expression of mifta (A, B, G, H), c-kit (C, D, I, J) and dct (E, F). (A, B, G, H) There are fewer mitfa-positive melanoblasts specified in hdac1col mutants as
compared to wild type. (C, D) Melanoblast-specific c-kit expression in hdac1col mutants is absent and/or reduced (arrowheads), although non-melanoblast expression
of c-kit in the post anal region and posterior mesoderm is equivalent to wild-type (arrows). (I, J) Similarly, in the cranial region melanoblast-specific c-kit expression is
reduced or absent, while c-kit expression in the branchial arches is more robust albeit disorganized in hdac1col mutants as compared to wild-type (arrowheads). (E, F)
There are fewer dct-positive differentiating melanoblasts in hdac1col mutants compared to wild-type (arrowheads) and most of the dct-positive melanoblasts are
located posterior to the otic vesicle in the dorsal stripe suggesting defects in migration. Also, there is a lack of dct-positive melanoblasts in the anterior head (arrow).
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positive melanoblasts are reduced in number and the melano-
blasts are restricted in distribution to the regions posterior to the
otic vesicle and in the dorsal stripe in the trunk at 25 hpf
in hdac1col mutants (Figs. 2E, F). dct expression levels in
hdac1col mutant melanoblasts also appears to be reduced as
compared to robust expression in wild-type melanoblasts at
25 hpf. Later at 30 hpf (Supplementary Figs. 2E, F), 36 hpf (data
not shown) and 48 hpf (Figs. 3E, F) most of the dct-positive
differentiating melanoblasts are located in the dorsal stripe in
the trunk and in a patch of cells just posterior to the otic vesicle,
indicating a failure in migration. Finally, reduced numbers of
dct-positive melanoblasts arise anterior to the otic vesicles at
all stages observed in hdac1col mutants. Taken together, the
mitfa, c-kit and dct expression data indicate that early
melanophore specification is delayed by an hour in hdac1col
mutants as compared to wild-type. There are also fewer
melanoblasts specified, and those that are have defects in
migration and differentiation.In contrast to delayed differentiation and migration of
melanophores and their precursors, in hdac1col mutants there
is no delay in the expression of xanthine dehydrogenase (xdh)
(Supplementary Figs. 2I, J and Fig. 3I, J), an enzyme that is
expressed in differentiating xanthoblasts (Parichy et al.,
2000a,b). Also, fms, a receptor tyrosine kinase orthrologue
of c-kit, required for xanthoblast survival and migration is
expressed robustly in hdac1col mutants and is equivalent to
wild-type embryos at all stages analyzed (Supplementary Figs.
2G, H and Fig. 3G, H) (Parichy et al., 2000a,b). Thus, normal
hdac1 function is selectively required for melanogenesis and
is not required for xanthophore differentiation and migration.
Neural crest cell induction and the migration of
non-melanogenic neural crest cells are unaffected
in hdac1col mutants
Since there is a reduction of melanophores and their
precursors during development, we decided to analyze the
Fig. 3. Melanophore development does not recover in hdac1colmutants. All panels are lateral views of 48 hpf embryos that are stained by in situ hybridization to reveal
expression of mifta (A, B), c-kit (C, D), dct (E, F), fms (G, H) and xdh (I, J). (A, B) By 48 hpf mitfa expression is switched off in differentiating melanoblasts in wild-
type; however in hdac1col mutants, mitfa continues to be expressed robustly in melanoblasts. (A, B, E, and F) There are still reduced numbers of mitfa and dct
expressing melanoblasts in hdac1col mutants as compared to wild-type. Additionally, there is still a migration defect as most of the mitfa and dct expressing
melanoblasts are located at their site of origin in the post otic region (arrowhead) and in the dorsal stripe (arrow). (C, D) In contrast to levels ofmitfa and dct expression
in melanoblasts in hdac1col mutants, c-kit expression in melanoblasts does not recover to wild-type levels (arrowheads). (G–J) Unlike melanophore development,
xanthophore number and migration recover by 48 hpf, where there are numerous migrating fms-positive and xdh-positive xanthoblasts in wild-type and hdac1col
mutants.
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neural crest cells to discern if there is a similar reduction in
neural crest cells in hdac1col mutants. At the 3- and 6-somite
stages, there is no difference in the neural crest cell expression
of tfap2a, sox9b, sox10 and snai1b between wild-type andhdac1col mutant embryos (Figs. 4A–D, data not shown). Later,
at the 14–15-somite stage there is no difference in the
expression of tfap2a, sox10, foxd3 and ctn between hdac1col
mutants and wild-type embryos (Figs. 4E–L). The early
expression of tfap2a, sox10, snai1b, sox9b, foxd3 and ctn
Fig. 4. Neural crest induction and migration of non melanogenic cells are largely unaffected in hdac1col mutants. In situ hybridizations for tfap2a (A, E, F), sox9b (B),
sox10 (C, G, H, O, P), snai1b (D), foxd3 (I, J) and ctn (K, L, M, N) between 3 somites (s) and 24 hpf. (A–D) Dorsal views of representative gene expression in 3 somite
embryos. Neural crest induction is normal and there is no difference in the expression of tfap2a, sox9b, sox10 and snai1b between wild-type and hdac1col mutants.
(E–L) Lateral views of 15 somite embryos. At the 15 s stage there is no difference in the expression and number of cranial and trunk neural crest cells (arrowheads)
expressing tfap2a (E, F), sox10 (G, H), foxd3 (I, J) and ctn (K, L) between wild-type and hdac1col mutants. (M–P) Lateral views of 24 hpf embryos. Later by 24 hpf
there is a slight reduction in the number of trunk neural crest cells expressing ctn and sox10 in hdac1colmutants compared to wild-type. However, the overall migration
of trunk neural crest cells in hdac1col mutants is largely unaffected although slightly delayed (arrows, arrowheads).
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induced in hdac1col mutants and wild-type embryos. By 24 hpf,
there is a slight decrease in the number of cells expressing ctn
and sox10 in the migrating trunk neural crest in hdac1col
mutants (Figs. 4M–P). There is also a slight delay in neural crest
cell migration in the trunk in hdac1col mutants. However,
relative to the reduction in mitfa in hdac1col mutants there are
many more ctn and sox10 positive neural crest cells present. In
cranial neural crest cells, there is no difference in the expression
of sox10 and ctn between wild-type and hdac1col mutants at
24 hpf, except in the region of the branchial arches where thereare fewer ctn positive cells migrating out of the post otic region
(data not shown). Overall, however, general neural crest
migration in the trunk is much more robust than the migration
of melanoblasts suggesting that non-melanoblast neural crest
cells successfully migrate, albeit after a brief delay.
Prolonged delay in the down regulation of foxd3 in hdac1col
mutants
Defects in melanophore development are first detectable at
the level of mitfa expression in hdac1col mutants. Therefore, we
575M.S. Ignatius et al. / Developmental Biology 313 (2008) 568–583looked at the expression of the transcription factors tfap2a,
foxd3, snai1b, sox9a/b and sox10 which are generally required
earlier than mitfa in neural crest cell development. After 24 hpf,
sox10 expression is downregulated in differentiating neural
crest cell derivatives in wild-type embryos. However, in
hdac1col mutants there is a delay in extinguishing sox10
expression and sox10 continues to be expressed robustly in
neural crest cells as late as 36 hpf and 52 hpf (unpublished data,
Figs. 5A, B). In addition to sox10, foxd3 is the only other
transcription factor in which there is a delay in downregulation
in hdac1col mutants compared to wild-type expression (Figs.
5C–J). Beginning at approximately 16 hpf, foxd3 expression is
extinguished in the premigratory neural crest in wild-type
embryos in a rostral to caudal fashion. By 24 hpf, foxd3 is only
expressed in cranial satellite glia and in the premigratory neural
crest at the tip of the tail (Fig. 5C). At 30 hpf, foxd3 is no longer
expressed in the neural crest but continues to be expressed in
cranial satellite glia (Kelsh et al., 2000a). In contrast, at 24 hpf
in hdac1col mutants, foxd3 continues to be expressed in trunk
neural crest cells, in addition to premigratory neural crest cells
in the tail region (Fig. 5D). In the cranial region, there is an
increase in foxd3-positive cells in hdac1col mutants compared
to wild-type embryos (Figs. 5E, F). The location of the foxd3-
positive cranial neural crest cells in the area of the cranialFig. 5. foxd3 expression is prolonged in the premigratory neural crest and increa
hybridizations of sox10 (A, B) and foxd3 (C–J) between 24 hpf and 52 hpf. (A, B
robustly in the dorsal stripe in hdac1col mutants, while expression in wild-type is ab
prolonged expression of foxd3 in the premigratory neural crest cells at 24 hpf in h
positive neural crest cells are mostly present at the tip of the tail (C, arrowhead).
expression is also increased in the somites in hdac1col mutants when compared to
that there is an increase in the number of cranial satellite glia in the pre otic and po
contrast, pineal gland foxd3 expression (arrows) in hdac1col mutants is slightly red
While foxd3 is not expressed in the premigratory neural crest cells in wild-type,
Lateral views of the head at 48 hpf. The number of foxd3-positive cranial satellite gl
type embryos (black arrow and white arrowheads).satellite glia suggests that there are more cranial satellite glial
cells in hdac1col mutants as compared to wild-type embryos.
However, as the domain of foxd3 expression is expanded in
hdac1col mutants relative to wild-type embryos, it is possible
that some of the foxd3 positive cells could also be undiffer-
entiated neural crest cells in addition to cranial satellite glia. At
30 hpf (data not shown) and 36 hpf (Figs. 5G, H), foxd3
continues to be expressed in the premigratory neural crest cells
in the tail, while in wild-type embryos, foxd3 is no longer
expressed. Finally, at 48 hpf, foxd3 is no longer expressed in the
premigratory neural crest cells in the tail and the number of
foxd3-positive presumptive cranial satellite glia in hdac1col
embryos is greater than in wild type (data not shown, Figs. 5I,
J). Thus, overall, there is a significant delay in the down-
regulation of foxd3 expression in neural crest cells in hdac1col
mutants.
Reduction of foxd3 expression in hdac1col mutants rescues
melanophore numbers and migration
The prolonged expression of foxd3 in trunk neural crest cells
and reduced expression of mitfa raised the possibility that
continued expression of foxd3, which can function as a
transcriptional repressor (Pohl and Knochel, 2001), could resultsed numbers of cranial satellite glia are present in hdac1col mutants. In situ
) Lateral views of 52 hpf embryos. At 52 hpf sox10 continues to be expressed
sent to faint (arrowheads). (C, D) Lateral views of 24 hpf embryos. There is a
dac1col mutants compared to wild-type (D, arrowheads). In wild-type, foxd3-
In addition to increased numbers of neural crest cells expressing foxd3, foxd3
wild-type. (E, F) Flat mounts of the cranial region of 24 hpf embryos indicate
st otic placodes (arrowheads) in hdac1col mutants as compared to wild-type. In
uced compared to wild-type. (G, H) Lateral views of the tail region at 36 hpf.
it is still expressed in this population in hdac1col mutants (arrowhead). (I, J)
ia associated with the cranial ganglia is much larger than those present in wild-
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et al., 2001). To test this hypothesis, we designed two strategies
to reduce foxd3 expression in hdac1col−/− mutants. First, we
knocked down FoxD3 protein using a translation blocking
morpholino (Stewart et al., 2006). The second approach was to
generate hdac1col−/−;foxd3zdf10−/− double mutants.
Twenty nanograms (ng) of the foxd3 morpholino per
embryo used in this study can phenocopy the complete loss of
sympathetic neurons in foxd3zdf10mutants, the foxd3 mutant
allele formerly known as foxd3sym1 (Stewart et al., 2006). In
our study, a 20-fold dilution of between 0.56 and 1.1 ng of
foxd3 morpholino per embryo was used to partially knock
down Foxd3. The injection of 0.56–1.1 ng of morpholino per
wild-type embryo results in the partial reduction in the
number of tyrosine hydroxylase-positive sympathetic neurons
at 56 hpf (Supplementary Figs. 1A–D). Partial knockdown of
Foxd3 resulted in an initial delay in melanophore differentia-
tion, as is the case in both hdac1col mutants and foxd3zdf10
mutants. In contrast, by 2 dpf (data not shown) and later at
3 dpf (Figs. 6A–D), there is an increase in melanophoreFig. 6. Repression of Foxd3 rescues melanogenesis in hdac1col mutants. Images of li
fewer melanophores present in hdac1col mutants at 3 dpf compared to wild-type emb
the site of origin in the post otic region, in the dorsal (d) stripe and in the anterior ventr
(d), lateral (l), ventral (v) and yolk (y). (C, D) Partial knockdown of Foxd3 in hdac1co
head (arrowhead), into the ventral stripe and over the yolk. (E, F) In control uninj
(arrowhead), in comparison the wild-type dorsal stripe is 2–3 melanophores wide (arr
(mo) in hdac1col mutants increases the migration of melanophores into the ventral s
morphants is only 2–3 melanophores wide (arrowhead).number and many more melanophores are migrating over the
anterior head, over the yolk and in the tail of hdac1col/foxd3
mutant/morphant embryos. In hdac1col embryos most of the
melanophores in the trunk fail to migrate and are located in
the dorsal stripe. As a result the dorsal stripe is at least 3–5
melanophores wide in hdac1col compared to the 2–3
melanophore wide dorsal stripe in wild-type (Figs. 6E, F).
Partial knockdown of Foxd3 via morpholino injection resulted
in the migration of melanophores from the dorsal stripe of the
hdac1col/foxd3 mutant/morphant embryos into the ventral
stripe and over the yolk sac. The resulting dorsal stripe in
hdac1col/foxd3 mutant/morphants is reduced to the wild-type
2–3 melanophore width (Figs. 6G, H).
To score for the rescue of melanophore number and
migration, the following 3 minimum criteria were established
based on the hdac1col mutant phenotype. First, there must be
migration of melanophores into the anterior head since very few
melanophores are found migrating over the head in hdac1col
mutants (Figs. 6B, D, arrowhead). Second, in the trunk, there
must be an increase in the migration of melanophores over theve embryos at 3 dpf, (A–D) lateral views, (E–H) dorsal views. (A, B) There are
ryos. Melanophores present in hdac1col mutants fail to migrate and are present at
al stripe. In wild-type embryos, melanophores migrate to form four stripes; dorsal
lmutants increases melanophore numbers and the melanophores migrate over the
ected hdac1col mutants the dorsal stripe (d) is usually 3–5 melanophores wide
owhead). (G, H) Partially reducing Foxd3 with a translation blocking morpholino
tripe and over the yolk, the resulting dorsal stripe in hdac1col/foxd3 mo mutant/
Table 3
Rescue of melanophore number and migration at 60 hpf in hdac1col mutants by
low dose of foxd3 morpholino injection
Trunk melanophores (±1 SD)
Melanophore # Melanophore migration
{Ventral (%)a}
wt hdac1col wt hdac1col
Uninjected
controls
109.71±8.71 68.29±10.73*** 43.26±2.43 12.19±3.23***
foxd3
morphants
92.71±17.1 86.27±11.13^ 45.27±9.48 37.57±9.41^^^
hdac1col mutants have significantly lower melanophore number than uninjected
wild-type embryos (***, Pb0.001). Partial knockdown of Foxd3 in hdac1col
mutants rescued melanophore number significantly, as compared to uninjected
hdac1col mutants (^, Pb0.05), also melanophore numbers between wild-type/
foxd3 morphants and hdac1col/foxd3 mutant/morphants were comparable.
Significantly lower migration was noted in hdac1col mutants embryos at 60 hpf
(***, Pb0.001). Partial knockdown of Foxd3 resulted in comparable
melanophore migration between hdac1col/foxd3 mutant/morphants, wild-type/
foxd3 morphants and wild-type embryos (^^^, PN0.05).
n=7 for all groups.
Melanophore migration {Ventral (%)a}; migration is calculated as a percentage
of melanophores in the ventral stripe to the total number of melanophores in the
dorsal, ventral and lateral stripes.
Two-way ANOVAwith Bonferroni post hoc test was performed.
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melanophores are only rarely present over the posterior yolk sac
and in the yolk extension region (Figs. 6B, D). Finally, in the
ventral stripe of the tail, there are usually between 0 and 6
melanophores present in hdac1col embryos (Figs. 6B, D).
Therefore, a rescued mutant must have more than 6 melano-
phores present. Based on these criteria, 84% of the hdac1col
embryos injected with foxd3 morpholino showed rescue of the
melanophore phenotype (n=72, Table 2a). We quantified the
rescue of melanophore number and migration by performing
melanophore cell counts at 60 hpf in somites 5 through 15 of the
trunk in wild-type/foxd3 morphant and hdac1col/foxd3 mutant/
morphant embryos (Table 3). Melanophore counts are a total of
pigmented melanophores present in the dorsal, ventral and
lateral stripes. There is a statistically significant increase in
melanophore numbers from 68±10.7 to 86±11.1 in hdac1col/
foxd3 mutant/morphants as compared to uninjected hdac1col−/−
mutants (Pb0.05). Additionally, wild-type and hdac1col−/−
embryos injected with foxd3 morpholino have statistically
equivalent number of melanophores in the trunk showing a
rescue of the melanophore phenotype at 60 hpf (92±17.1 vs.
86.3±11.13 melanophores, PN0.05). However, wild-type/
foxd3 morphants have fewer melanophores as compared to
uninjected wild-type embryos (92±17.1 vs. 109±8.7 melano-
phores, Pb0.05) at 60 hpf. This is consistent with the delay in
melanophore development in foxd3zdf10 mutants (Stewart et al.,
2006). In addition to the rescue of melanophore numbers, there
is a rescue in the migration of melanophores into the ventral
stripe in hdac1col/foxd3 mutant/morphant embryos as compared
to uninjected hdac1col−/− embryos (Table 3). The percentage of
melanophores that migrate into the ventral stripe is statisticallyTable 2
Rescue of melanophore number and migration in hdac1col mutants at 3 dpf by










hdac1col−/− a +/+ 0 2/134 (1.5%)
hdac1col−/−a +/+ 0.56–1.1 ng 61/72 (84.7%)
hdac1col−/−;foxd3zdf10+/+ b +/+ 0 0/20
hdac1col−/−;foxd3zdf10+/− +/- 0 7/34
hdac1col−/−;foxd3zdf10−/− +/- 0 0/21
Overall rescue
8/80 (10%)⁎
hdac1col−/−;foxd3zdf10+/+ b +/+ 0.477 ng 14/24
hdac1col−/−;foxd3zdf10+/− +/- 0.477 ng 36/41
hdac1col−/−;foxd3zdf10−/− +/- 0.477 ng 0/13
Overall rescue
50/80 (62.5%)⁎⁎
a Single hdac1col control and hdac1col/foxd3 mutant/morphant embryos
scored for rescue of the melanophore phenotype.
b Control and foxd3 morpholino treated hdac1col embryos obtained from a
hdac1col+−;foxd3zdf10+/− double heterozygous incross. Closely linked SSLP
marker z5294 was used to determine foxd3 genotype.
* Genotypes of 5/80 control embryos were not determined, including 1
rescued embryo.
** Genotypes of 2/80 embryos were not determined, 1 of the 2 embryos was a
potential double mutant based on phenotype.the same between wild-type uninjected, wild-type/foxd3
morphants and hdac1col/foxd3 mutant/morphant embryos at
60 hpf.
We then reduced foxd3 expression genetically by mating
hdac1col+/−;foxd3zdf10+/− double mutant heterozygous carriers.
There are 4 distinct phenotypes observed: wild-type, foxd3zdf10
mutants, hdac1col mutants and hdac1col;foxd3zdf10 double
mutants (Figs. 7A–D). In a heterozygous cross between double
mutant hdac1col+/−;foxd3zdf10+/− heterozygous carriers, the
following ratio of phenotypes was obtained wild-type:
hdac1col:foxd3zdf10:hdac1col;foxd3zdf10∷152:48:52:17 con-
firming a Mendelian 2 factor ratio of 9:3:3:1. Loss of
hdac1col and foxd3 function in hdac1col−/−;foxd3zdf10−/−
double mutants resulted in the reduction of the total number
of melanophores at all stages observed, compared to
foxd3zdf10−/− or hdac1col−/− single mutants or wild-type
embryos. This indicates a genetic interaction between
hdac1col and foxd3zdf10 in melanophore development which
is only revealed when both genes are simultaneously knocked
out. In separate genetic incrosses of hdac1col+/−;foxd3zdf10+/−
double heterozygous carriers, we observed that of the mutant
embryos which are phenotypically hdac1col, 10 % (n=80)
have a rescue of melanophore number and migration (Fig.
7E). Based on the hypothesis that foxd3 represses melanogen-
esis, we would predict that the rescued hdac1col mutants
should also be heterozygous for foxd3. Genotyping the
rescued hdac1col mutants for foxd3 allele status with closely
linked polymorphic SSLP marker z5294 revealed that all
rescued hdac1col mutants were also foxd3zdf10+/− (Table 2b).
Additionally, although not all completely satisfying the rescue
criteria, 42.5% (n=80) of hdac1col mutant embryos derived
from a double heterozygous cross (hdac1col+/−;foxd3zdf10+/−)
have more melanophores present, qualitatively and a greater
Fig. 7. Genetically reducing foxd3 rescues melanophore development in
hdac1col−/−;foxd3zdf10+/− mutants. (A–E) Live images with lateral views of 3.5
dpf embryos. Embryos obtained from a heterozygous incross of hdac1col+/−;
foxd3zdf10+/− carriers gave rise to 4 distinct phenotypes. (A) Wild-type that
have melanophores present in 4 distinct stripes: dorsal, lateral, ventral and
yolk. (B) foxd3zdf10 mutants in which the melanophore migration patterns have
largely recovered to resemble the wild-type. (C) hdac1col−/−;foxd3zdf10+/+ and
hdac1col−/−;foxd3zdf10+/− mutants whose melanophore phenotype resembles
single hdac1col−/− homozygous mutant phenotype. (D) hdac1col−/−;foxd3zdf10−/−
double mutants in which there is a reduction in melanophore numbers as well as
reduced migration into the lateral, ventral and yolk stripe locations. (E) 10% of
phenotypically hdac1col mutants that are hdac1col−/−;foxd3zdf10+/− display a
rescue of melanophore number as well as migration into the lateral, ventral and
yolk stripes.
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lateral and ventral stripes, especially in the tail region as
compared to more severe melanophore number and migration
defects in hdac1col−/− mutants obtained from a hdac1col+/− only
heterozygous incross. This is significant as we would expect
50% of hdac1col mutants from a hdac1col+/−;foxd3zdf10+/−
double heterozygous incross to also be heterozygous for
foxd3zdf10. Partial morpholino-mediated knockdown of foxd3
function in hdac1col mutants produced a more efficient (N80%
vs. 10%) rescue of melanophore number and migration as
compared to hdac1col+/−;foxd3zdf10+/−double mutant analysis. It
is possible that the level of Foxd3 present within the neural crest
cells is important for its function to repress melanogenesis and
that in many of the hdac1col−/−;foxd3zdf10+/− mutants Foxd3
levels are sufficiently high to prevent complete rescue of the
melanophore phenotype. Therefore, we reasoned then that, by
still further reducing Foxd3 using foxd3 morpholino in thehdac1col−/−;foxd3zdf10+/− or hdac1col−/−;foxd3zdf10+/+, mutants
would enhance the melanophore rescue phenotype. This was
observed, wherein 62.5% (n=80, Table 2b, Supplementary Figs.
3A–D) of phenotypically hdac1col mutants obtained from a
hdac1col+/−;foxd3zdf10+/− double heterozygous incross injected
with 0.477 ng of foxd3 morpholino have a complete rescue of
melanophore number andmigration. In contrast, reducing Foxd3
using morpholino in hdac1col−/−;foxd3zdf10−/− double mutants
which already completely lack functional Foxd3 has no effect on
melanophore recovery. Taken together, the morpholino and
double mutant approaches indicate that foxd3 represses
melanogenesis in hdac1col mutants and this repression can be
eliminated by partially reducing Foxd3 expression. Also, a
complete loss of foxd3 in hdac1col mutants results in more
severe melanophore defects as compared to relatively milder
defects in single hdac1col−/−or foxd3zdf10−/−mutants indicating a
genetic interaction between hdac1 and foxd3 in melanophore
development.
Foxd3 may repress melanogenesis at the level of mitfa
The observation that melanoblast-specific expression of both
mitfa as well as c-kit is significantly reduced in hdac1col
mutants raised the question as to whether foxd3 represses
melanogenesis at the level of either or both mitfa and c-kit. To
address this question we analyzed hdac1col/foxd3 mutant/
morphants for recovery of mitfa and/or c-kit expression. 84%
of hdac1col/foxd3 mutant/morphants have a recovery of
melanophore number and migration at 3 dpf. We performed
in situ hybridization for mitfa and c-kit in hdac1col/foxd3
mutant/morphant and wild-type/foxd3 morphant embryos with
uninjected wild-type and hdac1col mutants as controls. At
32 hpf, there is an increase in the number of mitfa-positive
melanoblasts in hdac1col/foxd3 mutant/morphants as compared
to uninjected hdac1col mutant embryos (Figs. 8A–D). In wild-
type/foxd3 morphant embryos, although there is no difference
in the number of mitfa-positive melanoblasts, qualitatively,
there is a slight decrease in the number of mitfa-positive
melanoblasts migrating as compared to uninjected wild-type
embryos. However, mitfa continues to be expressed robustly in
melanoblasts in wild-type/foxd3 morphants as well as hdac1col/
foxd3 mutant/morphants, when compared to uninjected wild-
type or hdac1col mutants. Next, we analyzed c-kit expression at
32 hpf in hdac1col/foxd3 mutant morphants and wild-type/
foxd3 morphants. In hdac1col/foxd3 mutant/morphants, c-kit
expression does not recover and is similar to uninjected
hdac1col mutants (Figs. 8E–H). In hdac1col/foxd3 mutant/
morphants embryos the rescue of the differentiated black
pigmented melanophore number and migration is only clearly
visible by 2 dpf. Therefore, we also analyzed c-kit expression
at 48 hpf in hdac1col/foxd3 mutant/morphants and wild-type/
foxd3 morphants. At 48 hpf, qualitatively there is a slight
increase in c-kit expression levels in hdac1col/foxd3 mutant
morphant embryos when compared to uninjected hdac1col
mutants (data not shown). However, c-kit expression in
hdac1col/foxd3 mutant/morphant melanoblasts remains signifi-
cantly reduced compared to wild-type or wild-type/foxd3
Fig. 8. Foxd3 negatively regulates mitfa. (A–D) Lateral views of mitfa in situ hybridizations of 32 hpf embryos. (B, D) There is an increase in the number of mitfa-
positive melanoblasts in hdac1col/foxd3 mutant/morphant embryos as compared to uninjected hdac1col mutants. (A, C) In wild-type/foxd3 morphant embryos mitfa
expression in melanoblasts is more robust than uninjected controls. (E–H) Lateral views of c-kit in situ hybridizations in 32 hpf embryos. (F, H) There is no rescue of
c-kit expression in melanoblasts in hdac1col/foxd3 mutant morphants when compared to uninjected hdac1col mutants at 32 hpf. (E, G) Qualitatively, there are fewer
c-kit positive melanoblasts in foxd3morpholino treated wild-type embryos as compared to uninjected wild-type embryos. (E–H) In contrast to melanoblast expression,
there is no difference in c-kit expression in the post anal region between wild-type, hdac1col mutants, wt/foxd3 wild-type/morphants and hdac1col/foxd3 mutant/
morphant embryos (arrows).
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cally represses melanogenesis at the level of mitfa and not c-kit
in hdac1col mutants. These data also correlate with the
expression pattern of foxd3 in wild-type embryos where at
16–18 s stages foxd3 is switched off in a rostral–caudal fashion
in the premigratory neural crest, while mitfa starts to be
expressed around the same time in a rostral–caudal fashion. In
hdac1col mutants, foxd3 fails to be downregulated and mitfa
expression is repressed.
Analysis of an 836 bp promoter region of mitfa which is
sufficient to drive melanoblast-specific expression of mitfa
(Dorsky et al., 2000) contains two putative foxd3 binding sites.
The predicted Foxd3 binding sites are located overlapping the
ATG transcriptional start site and 171 bp upstream of the
translation start site of mitfa. The −171 bp site is present
clustered between two functional sox10 (S1 and S3) binding
sites in the mitfa promoter region (Elworthy et al., 2003). We
decided to test whether Foxd3 can bind directly to the mitfa
promoter. We used electrophoretic mobility shift assays
(EMSA) to investigate the interaction of Foxd3 with thepredicted forkhead sites in the mitfa promoter. We found that in
vitro translated (IVT) Foxd3 was capable of interacting with
probes spanning either predicted forkhead site to form
complexes exhibiting retarded electrophoretic mobility (Fig.
9). We observed competition for formation of the complex using
an excess of unlabeled wild-type competitors. No competition
was observed when we added an excess of mutated or
nonspecific (OCTA) competitors. These results indicate that
Foxd3 can specifically interact with both predicted forkhead
binding sites in the mitfa promoter.
Discussion
Our analysis of the hdac1col mutant has revealed that hdac1
is indirectly required for melanogenesis during zebrafish neural
crest development. We found that expression of the transcrip-
tion factor foxd3 fails to be extinguished in neural crest cells of
hdac1col mutants in a temporally appropriate manner and that
concomitantly, mitfa expression and melanogenesis are sup-
pressed. We also found that Foxd3 is capable of physically
Fig. 9. Foxd3 can physically interact with predicted forkhead binding sites in the
mitfa promoter. Electrophoretic mobility shift assay (EMSA) using synthetic
Foxd3 protein, radiolabeled conserved region probes spanning the predicted
forkhead binding sites (Site 1 and Site 2), and unlabeled wild-type or mutated
site 1 or site 2 or unrelated (OCTA) oligonucleotide competitors. Arrows denote
specific bands observed with Foxd3 protein. wt—wild-type site 1 or site 2
competitors; Mut—mutated site 1 or site 2 competitors; NS—nonspecific
(OCTA) competitor; FP—free probe (arrowhead).
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foxd3 acts as a repressor of mitfa expression. Together, our
results suggest that hdac1 function is required to repress foxd3
expression thereby permitting the expression of mitfa and
melanophore specification of a subset of neural crest cells
during development. Thus, we identify hdac1 as a regulator of
neural crest development and identify a mechanism by which
foxd3 is capable of repressing melanogenesis.
The mechanism of action by which hdac1col affects the
expression of foxd3 within the neural crest is not known.
However, it is known that acetylation, deacetylation and other
post-translational modifications of histone tails, are important in
the regulation of chromatin structure, which in turn plays an
important role in regulating eukaryotic gene expression
(Jenuwein and Allis, 2001; Rice and Allis, 2001; Strahl and
Allis, 2000). Transcriptionally active chromatin usually has
highly acetylated histone cores and transcriptionally inactive
chromatin is associated with deacetylated histones (Ahringer,
2000; Allfrey, 1966). Histone acetylases (HATs) and histone
deacetylases (HDACs) are required to control the acetylation
and deacetylation of histones (Marks et al., 2003; Roth et al.,
2001). This suggests the possibility that the deacetylation
activity of Hdac1 is necessary to extinguish foxd3 expression, in
response to an unknown signal, and that the disruption of Hdac1
function in hdac1col mutants results in the failure to extinguish
foxd3 expression, resulting in the repression of melanogenesis.
However, in addition to regulating transcription via controlling
chromatin conformation, HATs and HDACs are also known toregulate several non-histone proteins via acetylation and
deacetylation. Changing the acetylation status on proteins has
been shown to regulate protein stability, protein–protein
interactions, sub-cellular localization of proteins and also to
regulate DNA binding (Minucci and Pelicci, 2006) suggesting
that gene regulation by HDACs including Hdac1 is likely to be
more complex than just histone acetylation states. Thus,
whether hdac1 directly regulates foxd3 expression and the
mechanism by which this regulation occurs will require further
investigation.
Our finding that repressing foxd3 expression in hdac1col
mutants rescues mitfa expression and melanogenesis can be
thought of as an experimental recapitulation of normal
development. Specifically, in wild-type zebrafish embryos, the
termination of neural crest foxd3 expression is temporally and
spatially contemporaneous with the induction of mitfa expres-
sion and melanophore specification. Our finding that Foxd3 is
capable of interacting at the mitfa promoter in vitro indicates the
possibility that this interaction could be direct in vivo.
Consistent with this possibility, it has been reported that
overexpression of foxd3 in melanoma cell lines repressed the
expression of endogenous mitf (Lister et al., 2005; Thomas and
Erickson, 2006). Also, in chick it has been reported that Foxd3
can repress luciferase expression driven by the chick Mitf
promoter and that Foxd3 can physically interact with the chick
Mitf promoter (Thomas and Erickson, 2006). However, a more
rigorous analysis of this interaction will be required to determine
whether it occurs directly in zebrafish embryos. In any case, it is
important to emphasize that the termination of foxd3 expression
is permissive, not instructive, for melanogenesis. This is
indicated by the fact that most if not all premigratory neural
crest cells express foxd3 whereas only a subset of the neural
crest cell population develop as melanophores. Instructive cues
likely include pax3, CREB, sox10 and lef1 based on their
demonstrated ability to positively regulatemitf (Bertolotto et al.,
1998; Bondurand et al., 2000; Dorsky et al., 2000; Elworthy et
al., 2003; Lee et al., 2000; Potterf et al., 2000; Price et al.,
1998b; Saito et al., 2002; Takeda et al., 2000; Verastegui et al.,
2000). However, as these factors are more broadly expressed in
the neural crest population than mitfa, it remains to be
determined what factors limit the induction of mitfa within the
neural crest cell population. Nevertheless, our results strongly
suggest that the termination of foxd3 expression during normal
development, mediated at least in part by hdac1, is required for
melanogenesis to occur (Fig. 10).
The effects of the hdac1col mutation on neural crest sox10
expression may be informative. Briefly, we found that, like
foxd3, sox10 expression is inappropriately extended in hdac1col
mutants. In fact, the expression of both transcription factors is
expanded among cranial neural crest cells and appears to result
in an expansion of cranial satellite glial numbers. This
consequence is consistent with the requirement for both sox10
and foxd3 in zebrafish for cranial satellite glial development
(Dutton et al., 2001; Kelsh and Eisen, 2000; Kelsh et al., 2000a;
Stewart et al., 2006). In contrast, the extension of neural crest
sox10 expression in hdac1col mutants might be predicted to
increase melanogenesis given the requirement for sox10 for
Fig. 10. A model for the regulation of the initiation of melanogenesis. (A)
Expression of foxd3 prohibits the expression of mitfa and the initiation of
melanogenesis by premigratory neural crest cells. Foxd3 is depicted as acting at
themitfa promoter, which can occur in vitro, but it is not known if this is the case
in vivo. (B) Prior to migration Hdac1 is required, directly or indirectly, to repress
neural crest foxd3 expression. Repression of foxd3 expression permits
transcriptional activation of mitfa by Sox10, Lef1 and other (O) regulators,
resulting in the initiation of melanogenesis by a subpopulation of neural crest
cells.
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and Eisen, 2000) and the direct positive regulation of mitfa by
sox10 (Elworthy et al., 2003). However, the fact that
melanogenesis remains suppressed in hdac1col mutants sug-
gests that sox10 is incapable of promoting mitfa expression
when foxd3 is expressed, further indicating a requirement for
foxd3 expression termination for melanogenesis via mitfa.
Consistent with our data, it has been reported that foxd3
represses sox10 mediated transcriptional activation of luciferase
driven by the 836 bp endogenous zebrafish mitfa promoter
(Lister et al., 2005). Although this suggests a hierarchical
relationship, more sensitive means of quantifying expression
than in situ hybridization will be required to detail the in vivo
regulation of mitfa by sox10 and foxd3.
The melanophore phenotype rescue of hdac1col mutants by
reducing foxd3 expression levels is somewhat surprising given
the apparent lack of a concomitant rescue of c-kit expression by
melanogenic neural crest cells. c-kit has been shown to be
required for melanophore migration and survival in zebrafish
(Parichy et al., 1999). Thus, the rescue of melanophore
migration in rescued hdac1col mutants in which c-kit remains
suppressed is puzzling. It is formally possible that repression of
foxd3 in hdac1col mutants results in the expression or
overexpression of an unknown factor or factors that facilitate
melanophore and melanophore precursor migration in the
absence of c-kit. Instead, we suggest that this apparent quandary
is most likely due to the relatively insensitive in situ
hybridization method of detecting gene expression. For
example, in the zebrafish c-kit mutant sparse (spa), melano-
phore migration fails, there is extensive melanophore cell death,
and a patch of melanophores forms behind the ear (Parichy
et al., 1999). While these phenotypes are also characteristic of
hdac1col mutants, they are less severe. For example, some
melanophores migrate and fewer die in hdac1col mutants than inspa mutants suggesting the presence of at least low levels of
c-kit expression in hdac1col mutant melanophores. Thus, we
speculate that c-kit expression in rescued hdac1col mutants is
elevated to levels permitting extensive migration and survival of
melanophores but at expression levels still below that which can
be readily detectable by in situ hybridization. Thus, we suggest
that the principle consequence on melanogenesis of foxd3
expression is the suppression of melanophore specification due
to the repression of mitfa.
Our data suggest a similar function of foxd3 in repressing
melanogenesis in zebrafish and chick systems, in contrast to
earlier studies in which there appeared to be differences. In
zebrafish, loss of foxd3 in foxd3zdf10 mutants generally does not
affect neural crest induction and does not affect melanophore
development, although there is a slight delay in differentiation
(Stewart et al., 2006). Additionally, in zebrafish, loss of function
of foxd3 suggests that foxd3 is required in premigratory and
migratory neural crest for subsets of neural crest derivatives
which include neurons and glia of the peripheral nervous system
and posterior elements of the pharyngeal skeleton (Lister et al.,
1999; Montero-Balaguer et al., 2006; Stewart et al., 2006). In
chick, electroporation of foxd3 into the neural tube induces a
neural crest cell-like fate (Cheung et al., 2005; Dottori et al.,
2001; Kos et al., 2001). In addition, foxd3 overexpression
prevents the migration of neural crest cells onto the dorso-lateral
pathway and most cells migrate along the medial pathway.
Neural crest cells that migrate on the dorso-lateral pathway in
avian embryos are exclusively melanophores and never express
foxd3, while those that migrate along the medial pathway form
neurons and glia and initially express foxd3, which is then
extinguished in late migrating neural crest cells (Dottori et al.,
2001; Kos et al., 2001). Furthermore, knockdown of Foxd3 via
morpholinos in avian neural crest cultures increases the
numbers of melanophores without affecting proliferation,
indicating that foxd3 represses melanogenesis (Kos et al.,
2001). Conflicting results obtained in chick and zebrafish argue
for differences between the chick and zebrafish systems.
However, our data reconcile differences between these two
systems by defining gain of function requirements of foxd3 in
zebrafish. In this study, we demonstrate that, as a result of
temporally abnormal foxd3 expression after it has normally
been extinguished in neural crest cells, fewer melanophores are
specified. This abnormal gain of function of foxd3 in the
hdac1col mutants along with a loss of function in foxd3zdf10
mutants and knockdown via morpholino suggests that, while
foxd3 is not necessary to specify melanophores, it can repress
specification when present. Reconciliation between the appar-
ent induction of neural crest-like cells in chick in response to
foxd3 misexpression and the absence of this effect in zebrafish
remains to be investigated.
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